Clinical Trial

Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-22; most recent amendment 2025-06-24.
Trial Details
NCT Number NCT06569953
Lead Sponsor The Second Affiliated Hospital of Chongqing Medical University
Collaborators: People's Hospital of Chongqing, LanZhou University, Xiangya Hospital of Central South University, Shapingba District People's Hospital of Chongqing
Conditions Acute Pain, Chronic Pain, Postoperative Pain
Enrollment 284 participants
Start Date 2024-08-26
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27